A prediction model for pathological findings after neoadjuvant chemoradiotherapy for resectable locally advanced esophageal squamous cell carcinoma based on endoscopic images using deep learning

被引:12
|
作者
Kawahara, Daisuke [1 ]
Murakami, Yuji [1 ]
Tani, Shigeyuki [2 ]
Nagata, Yasushi [1 ,3 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed Hlth Sci, Dept Radiat Oncol, Hiroshima, Japan
[2] Hiroshima Univ, Sch Med, Hiroshima, Japan
[3] Hiroshima High Precis Radiotherapy Canc Ctr, Hiroshima, Japan
来源
BRITISH JOURNAL OF RADIOLOGY | 2022年 / 95卷 / 1135期
关键词
CANCER; CT;
D O I
10.1259/bjr.20210934
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objectives: To propose deep-learning (DL)-based predictive model for pathological complete response rate for resectable locally advanced esophageal squamous cell carcinoma (SCC) after neoadjuvant chemoradiotherapy (NCRT) with endoscopic images. Methods and Material: This retrospective study analyzed 98 patients with locally advanced esophagus cancer treated by preoperative chemoradiotherapy followed by surgery from 2004 to 2016. The patient data were split into two sets: 72 patients for the training of models and 26 patients for testing of the model. Patients was classified into two groups with the LC (Group I: responder and Group II: non-responder). The scanned images were converted into joint photographic experts group (JPEG) format and resized to 150 Chi 150 pixels. The input image without imaging filter (w/o filter) and with Laplacian, Sobel, and wavelet imaging filters deep-learning model to predict the pathological CR with a convolution neural network (CNN). The accuracy, sensitivity, and specificity, the area under the curve (AUC) of the receiver operating characteristic were evaluated. Results: The average of accuracy for the cross-validation was 0.64 for w/o filter, 0.69 for Laplacian filter, 0.71 for Sobel filter, and 0.81 for wavelet filter, respectively. The average of sensitivity for the cross-validation was 0.80 for w/o filter, 0.81 for Laplacian filter, 0.67 for Sobel filter, and 0.80 for wavelet filter, respectively. The average of specificity for the cross-validation was 0.37 for w/o filter, 0.55 for Laplacian filter, 0.68 for Sobel filter, and 0.81 for wavelet filter, respectively. From the ROC curve, the average AUC for the cross-validation was 0.58 for w/o filter, 0.67 for Laplacian filter, 0.73 for Sobel filter, and 0.83 for wavelet filter, respectively. Conclusions: The current study proposed the improvement the accuracy of the DL-based prediction model with the imaging filters. With the imaging filters, the accuracy was significantly improved. The model can be supported to assist clinical oncologists to have a more accurate expectations of the treatment outcome. Advances in knowledge: The accuracy of the prediction for the local control after radiotherapy can improve with the input image with the imaging filter for deep learning.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer
    Song, SY
    Kim, JH
    Ryu, JS
    Lee, GTH
    Kim, SB
    Park, SI
    Song, HY
    Cho, KJ
    Ahn, SD
    Lee, SW
    Shin, SS
    Choi, EK
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (04): : 1053 - 1059
  • [32] Computed tomography-based deep-learning prediction of neoadjuvant chemoradiotherapy treatment response in esophageal squamous cell carcinoma
    Hu, Yihuai
    Xie, Chenyi
    Yang, Hong
    Ho, Joshua W. K.
    Wen, Jing
    Han, Lujun
    Lam, Ka-On
    Wong, Ian Y. H.
    Law, Simon Y. K.
    Chiu, Keith W. H.
    Vardhanabhuti, Varut
    Fu, Jianhua
    RADIOTHERAPY AND ONCOLOGY, 2021, 154 : 6 - 13
  • [33] Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma
    Cao, X. -F.
    He, X. -T.
    Ji, L.
    Xiao, J.
    Lv, J.
    DISEASES OF THE ESOPHAGUS, 2009, 22 (06) : 477 - 481
  • [34] Pathologic responses and surgical outcomes after neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma
    Xu, Lei
    Wei, Xiu-feng
    Li, Can-jun
    Yang, Zhao-yang
    Yu, Yong-kui
    Li, Hao-miao
    Xie, Hou-nai
    Yang, Ya-fan
    Jing, Wei-wei
    Wang, Zhen
    Kang, Xiao-zheng
    Zhang, Rui-xiang
    Qin, Jian-jun
    Xue, Li-yan
    Bi, Nan
    Chen, Xian-kai
    Li, Yin
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [35] Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
    He, Wenwu
    Leng, Xuefeng
    Mao, Tianqin
    Luo, Xi
    Zhou, Lingxiao
    Yan, Jiaxin
    Peng, Lin
    Fang, Qiang
    Liu, Guangyuan
    Wei, Xing
    Wang, Kangning
    Wang, Chenghao
    Zhang, Sha
    Zhang, Xudong
    Shen, Xudong
    Huang, Depei
    Yi, Huan
    Bei, Ting
    She, Xueke
    Xiao, Wenguang
    Han, Yongtao
    ONCOLOGIST, 2022, 27 (01): : E18 - E28
  • [36] A prospective study of apatinib in combination with neoadjuvant concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
    Wang, J.
    He, M.
    Yao, J.
    Cheng, Y.
    Wu, Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S931 - S931
  • [37] Neoadjuvant immune checkpoints inhibitors plus chemoradiotherapy for patients with locally advanced esophageal squamous cell carcinoma
    Kao, M-W.
    Hsieh, K-C.
    Rau, K-M.
    Ho, H-J.
    Huang, K-K.
    Kuo, Y-H.
    Hsieh, M-C.
    ANNALS OF ONCOLOGY, 2023, 34 : S1539 - S1539
  • [38] Long-term results of neoadjuvant chemoradiotherapy using cisplatin and 5-fluorouracil followed by esophagectomy for resectable, locally advanced esophageal squamous cell carcinoma
    Murakami, Yuji
    Hamai, Yoichi
    Emi, Manabu
    Hihara, Jun
    Imano, Nobuki
    Takeuchi, Yuki
    Takahashi, Ippei
    Nishibuchi, Ikuno
    Kimura, Tomoki
    Okada, Morihito
    Nagata, Yasushi
    JOURNAL OF RADIATION RESEARCH, 2018, 59 (05) : 616 - 624
  • [39] Immune cell patterns before and after neoadjuvant immune checkpoint blockade combined with chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
    Zheng, Dan-Dan
    Li, Yu-Ying
    Yuan, Xiao-Yi
    Lu, Jiang-Li
    Zhang, Mei-Fang
    Fu, Jia
    Zhang, Chris Zhiyi
    BMC CANCER, 2024, 24 (01)
  • [40] ASO Visual Abstract: Development and Validation of a Recurrence-Free Survival Prediction Model for Locally Advanced Esophageal Squamous Cell Carcinoma with Neoadjuvant Chemoradiotherapy
    Zhou, Yehan
    He, Wenwu
    Huang, Zongyao
    Liu, Yang
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (05) : 3489 - 3490